−7.3144USD
−5.57 MUSD
184.00 KUSD
657.59 K
About Titan Pharmaceuticals, Inc.
Sector
CEO
Gim Shen Seow
Headquarters
South San Francisco
Website
Employees (FY)
4
Founded
1992
ISIN
US8883141355
FIGI
BBG00QL565M5
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
